Par Pharmaceutical, Inc.

151 articles about Par Pharmaceutical, Inc.

• Par Pharmaceutical, Inc. Receives Final Approval to Market Generic Ultram(R) ER Par to Begin Shipping Tramadol ER Immediately

  11/16/2009

• Par Pharmaceutical, Inc. Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note

  11/10/2009

• Par Pharmaceutical, Inc. Reports EPS of $0.76 for Third Quarter 2009 Achieves Record Quarterly Gross Margin of $92 Million

  11/6/2009

• Par Pharmaceutical, Inc. Q3 Profit Beats Estimates on Strong Revenue

  11/6/2009

• Par Pharmaceutical, Inc. to Host Third Quarter 2009 Earnings Conference Call On November 6 at 9:00 am

  10/22/2009

• Par Pharmaceutical, Inc. Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010

  10/15/2009

• Par Pharmaceutical, Inc. Wins on Invalidity in Ultram(R) ER Litigation

  8/17/2009

• Biovail Corporation Comments on Ultram(R) ER Court Ruling

  8/17/2009

• Par Pharmaceutical, Inc. to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

  7/15/2009

• Par Pharmaceutical, Inc. Begins Shipment of Generic Miacalcin(R)

  6/9/2009

• Par Pharmaceutical, Inc. Begins Shipment of Generic Risperdal(R) M-TAB

  6/2/2009

• Par Pharmaceutical, Inc. Q1 Profit Jumps, Shares Rise

  5/6/2009

• Par Pharmaceutical, Inc. to Host First Quarter 2009 Earnings Conference Call on May 6 at 9:00 AM

  4/29/2009

• Par Pharmaceutical, Inc. Enters Into Agreement With Reliant Pharmaceuticals, Inc. to Settle Patent Litigation Over Rythmol(R) SR

  4/21/2009

• MDRNA, Inc. Sells Contract Manufacturing Operation to Par Pharmaceutical, Inc.

  4/1/2009

• Par Pharmaceutical, Inc. Reports Fourth Quarter and Full Year 2008 Results

  3/3/2009

• Par Pharmaceutical, Inc. to Host Fourth Quarter and Full Year 2008 Results Conference Call on March 3 at 9:00 am

  2/26/2009

• Par Pharmaceutical, Inc. Announces Outcome of the Litigation With Pentech Pharmaceuticals, Inc.

  2/10/2009

• Par Pharmaceutical, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference

  1/8/2009

• Par Pharmaceutical, Inc. Announces the Resignation of Its Chief Financial Officer

  12/12/2008